omeprazole has been researched along with Rhabdomyolysis in 6 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Polymyositis occurring in patients treated with omeprazole has been signalled as a possible adverse drug reaction (ADR) by the New Zealand Intensive Medicines Monitoring Programme (IMMP) and the WHO Collaborating Centre for International Drug Monitoring: the Uppsala Monitoring Centre (UMC)." | 4.83 | Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? ( Clark, DW; Strandell, J, 2006) |
| " We report on the case of an emergency department patient with omeprazole-induced hyponatremic delirium and rhabdomyolysis." | 3.74 | Proton pump inhibitor-induced rhabdomyolysis and hyponatremic delirium. ( Bebarta, VS; King, JA; McDonough, M, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, K | 1 |
| Nakada, TA | 1 |
| Abe, R | 1 |
| Itoga, S | 1 |
| Nomura, F | 1 |
| Oda, S | 1 |
| Nozaki, M | 1 |
| Suzuki, T | 1 |
| Hirano, M | 1 |
| Clark, DW | 1 |
| Strandell, J | 1 |
| Bebarta, VS | 1 |
| King, JA | 1 |
| McDonough, M | 1 |
| Yusoff, IF | 1 |
| Nairn, P | 1 |
| Morgan, CA | 1 |
| Dehesa, C | 1 |
| Kassel, G | 1 |
1 review available for omeprazole and Rhabdomyolysis
| Article | Year |
|---|---|
Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adverse Drug Reaction Reporting Systems; Enzyme Inhibitors; | 2006 |
5 other studies available for omeprazole and Rhabdomyolysis
| Article | Year |
|---|---|
Omeprazole-associated rhabdomyolysis.
Topics: Adult; Anti-Ulcer Agents; Duodenal Ulcer; Humans; Male; Omeprazole; Proton Pump Inhibitors; Rhabdomy | 2014 |
Rhabdomyolysis associated with omeprazole.
Topics: Anti-Ulcer Agents; Humans; Male; Middle Aged; Omeprazole; Rhabdomyolysis | 2004 |
Proton pump inhibitor-induced rhabdomyolysis and hyponatremic delirium.
Topics: Delirium; Humans; Hyponatremia; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rhabdomyolysi | 2008 |
Multiple organ failure related to pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acidosis, Lactic; Acute Kidney Injury; Aged; Anti-Ulcer Age | 1999 |
Multiple organ failure and pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Humans; Multiple Organ F | 2000 |